Summary:We report two patients who developed atypical skin lesions caused by Curvularia sp. and Pseudallescheria boydii after allogeneic bone marrow transplantation for severe aplastic anemia. The first patient (female, 18-year-old) had multiple hemorrhagic vesicles on day +30 after her second BMT for graft failure. Pseudallescheria boydii was isolated from a skin biopsy. The patient died of respiratory failure probably as a consequence of systemic fungal infection. The second patient (male, 9-yearold) developed an ecthyma gangrenosum-like lesion on his right palm on day +8. Curvularia sp. was isolated from a skin biopsy. Liposomal amphotericin was given to achieve a total dose of 30 mg/kg and followed by oral itraconazole until steroids were discontinued. The infection resolved completely and the patient has remained disease-free. We conclude that emerging fungal organisms such as those described in this report are increasingly recognized in this setting. Early recognition and biopsy of these cutaneous lesions will allow prompt initiation of therapy to prevent systemic infection. Bone Marrow Transplantation (2001) 27, 1311-1313. Keywords: Curvularia sp.; Pseudallescheria boydii; bone marrow transplantation; fungal infection Fungal infections cause significant morbidity and mortality in bone marrow transplant recipients. 1 Candida and Aspergillus sp. are the most common fungal pathogens in this setting although new fungal opportunists (hyalohyphomycoses and phaeohyphomycoses) may occasionally be isolated and identified as being responsible for local or systemic infections. 2,3 The purpose of this report is to describe the clinical manifestations and the mycological findings of two patients after allogeneic BMT who developed atypical skin lesions caused by unusual opportunistic fungi.
Case reports
Patient 1An 18-year-old woman diagnosed with hepatitis-associated severe aplastic anemia underwent BMT from her HLAidentical brother. Serologic tests for hepatitis A, B and C virus were negative. Conditioning consisted of CY 200 mg/kg and horse antilymphocyte globulin (PasteurMérieux, Lyon, France) 90 mg/kg. GVHD prophylaxis was a combination of CsA and short-course MTX. On day +5 a tender erythematous nodule was detected on her right leg. The patient was experiencing severe myalgia and flu-like symptoms. Direct examination of the skin biopsy revealed the presence of septate hyphae, so amphotericin B deoxycholate was administered. Fusarium solani was identified in the culture obtained from the skin biopsy. For the first 5 days, the lesion developed into a violet nodule with a necrotic center and then improved gradually leaving a hypopigmented scar. The patient's condition improved gradually. Amphotericin B deoxycholate was replaced by itraconazole 200 mg/day after engraftment and it was continued up to day +90. No recurrence of fungal infection was noted.However, the patient experienced graft failure 4 months after BMT. A second BMT was performed from another HLA-identical brother after conditioning with TBI 12 Gy and ...